Clorox Stock Plummets -8% With 6-Day Losing Streak
Clorox (CLX) – a manufacturer of consumer and professional cleaning and wellness products – hit a 6-day losing streak, with cumulative losses over this period amounting to -8%. The company’s market cap has crashed by about $1.1 Bil over the last 6 days and currently stands at $13 Bil.
Is this opportunity or trap? There are several things to fear in CLX stock given its overall Weak operating performance and financial condition. This isn’t appropriately reflected in the stock’s Moderate valuation which is why we think it is Unattractive (For details, see Buy or Sell CLX).
But here is the interesting part. You are reading about this -8% move after it happened. The market has already priced in the news. To manage individual stock risk before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to manage stock-specific drawdowns better.
Returns vs S&P 500
- Johnson & Johnson Stock Surged 60%, Here’s Why
- How Amazon Stock Behaves During Market Shocks
- Is Philip Morris International Stock Undervalued Stock Or Value Trap?
- Will Musk’s $1.6 Trillion Disruption Be His Biggest Yet?
- Rocket Lab’s $35 Billion Valuation Makes Little Sense – Until You Look at 2035
- Does Alphabet Stock Still Have Room to Run?
The following table summarizes the return for CLX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CLX | S&P 500 |
|---|---|---|
| 1D | -2.7% | -0.4% |
| 6D (Current Streak) | -8.0% | -2.1% |
| 1M (21D) | -18.7% | -4.1% |
| 3M (63D) | 6.0% | -4.1% |
| YTD 2026 | 3.4% | -4.2% |
| 2025 | -35.6% | 16.4% |
| 2024 | 17.7% | 23.3% |
| 2023 | 5.0% | 24.2% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 45 S&P constituents with 3 days or more of consecutive gains and 42 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 19 | 20 |
| 4D | 22 | 4 |
| 5D | 0 | 8 |
| 6D | 2 | 7 |
| 7D or more | 2 | 3 |
| Total >=3 D | 45 | 42 |
Key Financials for Clorox (CLX)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $7.1 Bil | $7.1 Bil |
| Operating Income | $723.0 Mil | $1.2 Bil |
| Net Income | $280.0 Mil | $810.0 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ1 | 2026 FQ2 |
|---|---|---|
| Revenues | $1.4 Bil | $1.7 Bil |
| Operating Income | $120.0 Mil | $236.0 Mil |
| Net Income | $80.0 Mil | $157.0 Mil |
The losing streak CLX stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.